stockrowLakefront Biotherapeutics - Sponsored ADR (LKFT) vs Vericel Corporation (VCEL)
- Lakefront Biotherapeutics - Sponsored ADR LKFT 33.37 −0.57%
- Vericel Corporation VCEL 54.47 +5.20%
Lakefront Biotherapeutics - Sponsored ADR and Vericel Corporation are both Biotechnology companies. Vericel Corporation is the larger, with a market value of $2.7B against $2.2B — 1.2× the size. Lakefront Biotherapeutics - Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 77.8×. Vericel Corporation grew revenue faster over the last twelve months: 25.3% against −52.2%. Vericel Corporation has the higher net margin (10.3% vs −6.81%) and the higher return on invested capital (7.88% vs 0.00%). Across the 20 metrics below, Vericel Corporation leads on 12 and Lakefront Biotherapeutics - Sponsored ADR on 8.
Valuation
Profitability
| Metric | LKFT | VCEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 89.75% | 74.47% | 65.16% |
| Operating margin | (90.11%) | 8.32% | 0.00% |
| Net margin | (6.81%) | 10.27% | 0.00% |
| Free cash flow margin | 0.00% | 17.86% | 0.00% |
| Return on equity | 0.00% | 9.44% | (50.12%) |
| Return on assets | 0.00% | 6.86% | (45.60%) |
| Return on invested capital | 0.00% | 7.88% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack